JP Stock MarketDetailed Quotes

4559 Zeria Pharmaceutical

Watchlist
  • 2282
  • 00.00%
20min DelayTrading Aug 27 13:06 JST
121.22BMarket Cap13.01P/E (Static)

Zeria Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zeria Pharmaceutical Q1 2025 Earnings Date

Currency：JPYAug 1, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
21.46B
+21.46B
Beat Est.
-100.00%
+17.22%
--
EPS
0
95.57
+95.57
Beat Est.
-100.00%
+44.50%
--
Analyst Rating
Strong Buy

Jul 10, 2024

Zeria Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Aug 1, 20242025/Q121.455B / ----
May 9, 20242024/Q417.806B / 17.780B--
Feb 1, 20242024/Q321.241B / 19.470B--
Nov 1, 20232024/Q218.374B / 18.295B--
Aug 3, 20232024/Q118.304B / 17.190B--
DatePeriodRevenue/EstimateEarnings Call
Aug 1, 20242025/Q121.455B / ----
May 9, 20242024/Q417.806B / 17.780B--
Feb 1, 20242024/Q321.241B / 19.470B--
Nov 1, 20232024/Q218.374B / 18.295B--
Aug 3, 20232024/Q118.304B / 17.190B--

Unlock Free Earnings Estimates

Zeria Pharmaceutical Earnings Reports

  • Zeria Pharmaceutical: 1st quarter financial results for the March 2025 period (consolidated) based on Japanese standards.

    Aug 1 03:00 ET

  • Zeria Pharmaceutical: Extraordinary Report

    Jul 2 21:44 ET

  • Zeria Pharmaceutical: Confirmation letter

    Jun 27 01:11 ET

  • Zeria Pharmaceutical: Securities Report - 70th period (April 1, 2023 - March 31, 2024)

    Jun 27 01:07 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 10, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg